亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy

嵌合抗原受体 纳米技术 癌症治疗 材料科学 免疫疗法 细胞疗法 癌症免疫疗法 医学 癌症 细胞 生物 内科学 遗传学
作者
Waqas Nawaz,Shijie Xu,Yanlei Li,Bilian Huang,Xilin Wu,Zhiwei Wu
出处
期刊:Acta Biomaterialia [Elsevier BV]
卷期号:109: 21-36 被引量:56
标识
DOI:10.1016/j.actbio.2020.04.015
摘要

Chimeric antigen receptor (CAR) therapy has achieved remarkable clinical efficacy against hematological cancers and has been approved by FDA for treatment of B-cell tumors. However, the complex manufacturing process and limited success in solid tumors hamper its widespread applications, thus prompting the development of new strategies for overcoming the abovementioned hurdles. In the last decade, nanotechnology has provided sustainable strategies for improving cancer immunotherapy through vaccine development and delivery of immunomodulatory drugs. Nanotechnology can boost CAR-T therapy and may overcome the existing challenges by emerging as a carrier for CAR-T therapy or in combination with CAR-T, it may inhibit solid tumors more effectively than conventional approaches. The revealing of cellular mechanisms, barriers and potential strategies that could be used to manipulate and/or modify cells would enable unprecedented advances in nanotechnology for biologics delivery. This review outlines the journey and barriers of nanoparticles (NPs) across the cell. Subsequently, the approaches to tackle the barriers and strategies to modulate NPs as a carrier for CAR-T therapy are discussed. Finally, the role of NPs in CAR-T therapy and the potential challenges are summarized. This review aims to provide the readers with a detailed overview of NP-based CAR-T therapy research and distil this information into an accessible form conducive to design desired CAR-T therapy using NP approach. Chimeric antigen receptor (CAR) T-cell therapy is the most vibrant field in immuno-oncology today, with enormous benefits to patients with B-cell malignancies. However, a rapid and straightforward procedure for CAR-T generation is an exigent need to broaden its therapeutic avenue. Nanotechnology has emerged as a novel alternative approach for CAR-T generation. To the best of our knowledge, this is the first in-depth review that briefly highlights the various aspects of nanotechnology in CAR-T therapy, including the strategies to brand NPs as an effective carrier for CAR cargo, its potential advantages, challenges, and future roadmap. It provides readers with a detailed overview of NP-based CAR-T therapy research, and researchers would be able to distill this information into an accessible form conducive to design the desired CAR therapy using the nanotechnology approach.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
fat完成签到,获得积分10
3秒前
123发布了新的文献求助10
4秒前
脑洞疼应助lf采纳,获得10
15秒前
健壮的花瓣完成签到 ,获得积分10
18秒前
oywt发布了新的文献求助10
26秒前
霸气鞯完成签到 ,获得积分10
27秒前
27秒前
lf发布了新的文献求助10
30秒前
30秒前
31秒前
33秒前
bbdd2334发布了新的文献求助10
34秒前
35秒前
39秒前
李健的小迷弟应助bbdd2334采纳,获得10
41秒前
42秒前
忧伤的风华完成签到,获得积分10
48秒前
thanhvader999完成签到,获得积分10
48秒前
小乘号子发布了新的文献求助10
49秒前
量子星尘发布了新的文献求助10
50秒前
51秒前
小马甲应助科研通管家采纳,获得10
52秒前
52秒前
科研通AI2S应助科研通管家采纳,获得10
52秒前
52秒前
轻松的惜芹应助白日梦采纳,获得20
53秒前
54秒前
悦耳的沛岚完成签到,获得积分10
54秒前
57秒前
Xiaowen发布了新的文献求助10
57秒前
123发布了新的文献求助10
1分钟前
学习使人头大完成签到 ,获得积分10
1分钟前
jyy应助坚定灯泡采纳,获得10
1分钟前
1分钟前
3080完成签到 ,获得积分10
1分钟前
小芭乐完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976600
求助须知:如何正确求助?哪些是违规求助? 3520700
关于积分的说明 11204482
捐赠科研通 3257320
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877881
科研通“疑难数据库(出版商)”最低求助积分说明 806613